Antepartum Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report View Sample

Published: October 29, 2021 Report Code: GDME1188EPD-ST

Select Item

Antepartum monitors refer to devices monitoring both maternal and fetal vital signs such as fetal/maternal heart rates, fetal ECG, maternal ECG, pulse oximetry, maternal BP, and uterine activity, during and before delivery. This is used on a routine basis throughout pregnancy. GlobalData's Medical Devices sector report, “Antepartum Monitors (Healthcare IT) – Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Antepartum Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

The Antepartum Monitors report provides key information and data related to:
Extensive coverage of the Antepartum Monitors under development
Review details of major pipeline products which include product description, licensing and collaboration details and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates
Reviews of major players involved in the pipeline product development.
Provides key clinical trial data related to ongoing clinical trials such as trial phase, trial status, trial start and end dates, and, the number of trials of the major Antepartum Monitors pipeline products.
Review of Recent Developments in the segment / industry
The Antepartum Monitors report enables you to:
Access significant competitor information, analysis, and insights to improve your R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Antepartum Monitors under development
Formulate market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
The GlobalData Differentiation

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

The data and analysis within this report are driven by GlobalData Medical Intelligence Center (GDMIC) database. GDMIC gives you the key information required to drive sales, investment and deal-making activity in your business. It includes the following:

• 15,000+ data tables showing market size across more than 780 medical equipment segments and 39 countries, from 2015 and forecast to 2025
• 6,700+ industry-leading analysis reports covering sector reports, medipoint reports, country analysis, expert insights and industry analysis (devices and procedures) reports
• 64,000+ medical equipment company profiles
• 5,600+ company profiles of medical equipment manufacturers in China and India
• 2,200+ company profiles of medical equipment manufacturers in Japan
• 1,200+ companies’ revenue splits and market shares
• 1,600+ quarterly and annual medical equipment company financials
• 850+ medical equipment company SWOTs
• 28,000+ pipeline product profiles
• 56,400+ marketed product profiles
• 47,000+ clinical trials
• 41,500+ trial investigators
• 7,000+ reports on companies with products in development
• 44,000+ deals in the medical equipment industry
• 1,100+ surgical and diagnostic procedures by therapy area
• 50+ key healthcare indicators by country
• 431,000+ Themes Content Items
• 600+ Influencers
• 1,900+ Analysts & Researchers
• 0.5m+ Community Members
• 141,000+ Macroeconomic Indicators
• 1,013,000+ City Indicators

For more information or to receive a free demonstration of the service, please visit:
https://medical.globaldata.com/home.aspx
Custom Requirements
Contact us to discuss the areas of your business where you need external input, and we will work with you to identify the strongest way forward to meet your needs.

Scope

– Extensive coverage of the Antepartum Monitors under development

– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

– The report reviews the major players involved in the development of Antepartum Monitors and list all their pipeline projects

– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

– The report provides key clinical trial data of ongoing trials specific to pipeline products

– Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

– Formulate significant competitor information, analysis, and insights to improve R&D strategies

– Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage

– Identify and understand important and diverse types of Antepartum Monitors under development

– Develop market-entry and market expansion strategies

– Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

– In-depth analysis of the product’s current stage of development, territory and estimated launch date

Biorithm Pte Ltd
Brun Health Pvt Ltd
Drexel University
Empathy Design Labs Pvt Ltd
King Abdullah University of Science and Technology
Lifewave Biomedical Inc
MBDevice
LLC
Neoventa Medical AB
Pradin Technologies Pvt Ltd
Sonica Ltd

Table of Contents

|1 Table of Contents 3

|1.1 List of Tables 5

|1.2 List of Figures 6

2 Introduction 7

2.1 Antepartum Monitors Overview 7

3 Products under Development 8

3.1 Antepartum Monitors – Pipeline Products by Stage of Development 8

3.2 Antepartum Monitors – Pipeline Products by Territory 9

3.3 Antepartum Monitors – Pipeline Products by Regulatory Path 10

3.4 Antepartum Monitors – Pipeline Products by Estimated Approval Date 11

3.5 Antepartum Monitors – Ongoing Clinical Trials 12

4 Antepartum Monitors – Pipeline Products under Development by Companies 13

4.1 Antepartum Monitors Companies – Pipeline Products by Stage of Development 13

4.2 Antepartum Monitors – Pipeline Products by Stage of Development 14

5 Antepartum Monitors Companies and Product Overview 15

5.1 Biorithm Pte Ltd Company Overview 15

5.1.1 Biorithm Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 15

5.2 Brun Health Pvt Ltd Company Overview 19

5.2.1 Brun Health Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

5.3 Drexel University Company Overview 20

5.3.1 Drexel University Pipeline Products & Ongoing Clinical Trials Overview 20

5.4 Empathy Design Labs Pvt Ltd Company Overview 21

5.4.1 Empathy Design Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

5.5 King Abdullah University of Science and Technology Company Overview 22

5.5.1 King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 22

5.6 Lifewave Biomedical Inc Company Overview 23

5.6.1 Lifewave Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 23

5.7 MBDevice, LLC Company Overview 24

5.7.1 MBDevice, LLC Pipeline Products & Ongoing Clinical Trials Overview 24

5.8 Neoventa Medical AB Company Overview 25

5.8.1 Neoventa Medical AB Pipeline Products & Ongoing Clinical Trials Overview 25

5.9 Pradin Technologies Pvt Ltd Company Overview 26

5.9.1 Pradin Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

5.10 Sonica Ltd Company Overview 27

5.10.1 Sonica Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

6 Antepartum Monitors- Recent Developments 28

6.1 Sep 20, 2021: Co-Diagnostics to Present at Sidoti Virtual Investor Conference 28

6.2 Aug 26, 2021: Pfizer Announces New Chief Business Innovation Officer 28

6.3 Aug 06, 2021: Meridian Bioscience Reports Third Quarter Fiscal 2021 Results 28

6.4 Jul 29, 2021: QIAGEN Reports Full Results for Q2 and H1 2021 32

6.5 Jul 28, 2021: Pfizer Announces Unaudited Financial Results For The Quarter Ended June 30, 2021. 34

6.6 May 27, 2021: Investment breakthrough for BrainRepair UG start-up – Stem cell treatment for newborns 34

6.7 May 17, 2021: QIAGEN Announces Creation of Scientific Advisory Board and Agenda for Annual General Meeting in June 2021 34

6.8 May 07, 2021: Meridian Bioscience Reports Strong Growth in Net Revenues and EPS in Second Quarter Fiscal 2021 35

6.9 Apr 15, 2021: Pfizer Invites Shareholders to Attend Virtual-Only 2021 Annual Meeting of Shareholders on April 22 36

6.10 Mar 16, 2021: Co-Diagnostics Invited to Present at Maxim Group Emerging Growth Virtual Conference 37

6.11 Mar 08, 2021: Co-Diagnostics to Discuss Recent Company Advances at H.C. Wainwright Global Life Sciences Virtual Conference 37

6.12 Mar 04, 2021: Meridian Bioscience to Participate in H.C. Wainwright Global Life Sciences 2021 Virtual Conference 37

6.13 Feb 22, 2021: QIAGEN Expands Supervisory Board With Appointment of a New Member 38

6.14 Feb 02, 2021: Pfizer Reports Mixed Q4 Results 38

6.15 Jan 26, 2021: QIAGEN N.V. to Report Fourth Quarter and Full-Year 2020 Results 38

6.16 Jan 13, 2021: Meridian Bioscience to Hold First Quarter Fiscal 2021 Financial Results Conference Call on February 5, 2021 39

6.17 Jan 07, 2021: Co-Diagnostics to Present at H.C. Wainwright BioConnect 2021 Virtual Conference 39

6.18 Nov 10, 2020: Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings Webcast 39

6.19 Oct 27, 2020: QIAGEN N.V. to hold investor call on Wednesday, October 28, after releasing results for Q3 2020 and first nine months of 2020 40

7 Appendix 41

7.1 Methodology 41

7.2 About GlobalData 44

7.3 Contact Us 44

Table

Antepartum Monitors – Pipeline Products by Stage of Development 8

Antepartum Monitors – Pipeline Products by Territory 9

Antepartum Monitors – Pipeline Products by Regulatory Path 10

Antepartum Monitors – Pipeline Products by Estimated Approval Date 11

Antepartum Monitors – Ongoing Clinical Trials 12

Antepartum Monitors Companies – Pipeline Products by Stage of Development 13

Antepartum Monitors – Pipeline Products by Stage of Development 14

Biorithm Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 15

Femom – Home Use – Product Status 15

Femom – Home Use – Product Description 15

Femom – Hospital Use – Product Status 16

Femom – Hospital Use – Product Description 16

Biorithm Pte Ltd – Ongoing Clinical Trials Overview 17

Femom – Hospital Use – This Clinical Study Evaluates the Performance and Safety of Biorithm Research Kit Versus CTG in Prenatal Monitoring of Pregnant Participants. 18

Brun Health Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 19

Brün – Product Status 19

Brün – Product Description 19

Drexel University Pipeline Products & Ongoing Clinical Trials Overview 20

Belly Band – Product Status 20

Belly Band – Product Description 20

Empathy Design Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 21

KRIYA – Product Status 21

KRIYA – Product Description 21

King Abdullah University of Science and Technology Pipeline Products & Ongoing Clinical Trials Overview 22

Fetal ECG Monitoring Device – Product Status 22

Fetal ECG Monitoring Device – Product Description 22

Lifewave Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 23

FetalConnect – Antepartum – Product Status 23

FetalConnect – Antepartum – Product Description 23

MBDevice, LLC Pipeline Products & Ongoing Clinical Trials Overview 24

MBDevice – Product Status 24

MBDevice – Product Description 24

Neoventa Medical AB Pipeline Products & Ongoing Clinical Trials Overview 25

Integrated Fetal Monitor – Product Status 25

Integrated Fetal Monitor – Product Description 25

Pradin Technologies Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 26

FetalMom – Product Status 26

FetalMom – Product Description 26

Sonica Ltd Pipeline Products & Ongoing Clinical Trials Overview 27

Wearable Monitoring System – Preterm Labor – Product Status 27

Wearable Monitoring System – Preterm Labor – Product Description 27

Figures

Antepartum Monitors – Pipeline Products by Stage of Development 8

Antepartum Monitors – Pipeline Products by Territory 9

Antepartum Monitors – Pipeline Products by Regulatory Path 10

Antepartum Monitors – Pipeline Products by Estimated Approval Date 11

Frequently asked questions

Antepartum Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Antepartum Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Healthcare IT reports
Medical Devices
New
PTA Peripheral DCB Catheters Pipeline by Development Stages, Segments, Region…
$4,000 | March 2024
Medical Devices
New
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Medical Devices
New
Immunochemistry Analyzers Market Size by Segments, Share, Regulatory, Reimbursement, Installed…
$7,500 | March 2024
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Antepartum Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 in real time.

  • Access a live Antepartum Monitors Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more